nevirapine has been researched along with raltegravir potassium in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffmann, HH; Kunz, A; Palese, P; Shaw, ML; Simon, VA | 1 |
| Back, DJ; Else, LJ; Khoo, SH; Taylor, S | 1 |
| Albanese, A; Asmuth, DM; Hayes, T; Knight, TH; Ma, ZM; Mann, S; Melcher, GP; Miller, CJ; Pollard, RB; Troia-Cancio, P; Yotter, T | 1 |
| Allavena, C; Bouquié, R; Dailly, E; Deslandes, G; Jolliet, P; Raffi, F | 1 |
| Barreiro, P; Fernández-Montero, JV; Labarga, P; Soriano, V; Vispo, E | 1 |
| Allavena, C; André-Garnier, E; Bettinger, D; Chirouze, C; Ferré, V; Hoen, B; Muret, P; Peytavin, G; Raffi, F; Reliquet, V | 1 |
| Cucchetto, G; Lanzafame, M; Lattuada, E; Nicole, S; Rigo, F; Vento, S | 1 |
| Borderi, M; Calza, L; Colangeli, V; Conti, M; Magistrelli, E; Mancini, R; Viale, P | 1 |
| Bonora, S; Calcagno, A; Calza, L; Capetti, A; Cenderello, G; D'Avolio, A; Di Perri, G; Guaraldi, G; Lanzafame, M; Marinaro, L; Montrucchio, C; Tettoni, MC; Trentini, L | 1 |
| Bonczkowski, P; Borch, A; De Scheerder, MA; De Spiegelaere, W; Koenig, R; Malatinkova, E; Melkova, Z; Vandekerckhove, L | 1 |
| Bon, I; Borderi, M; Bussini, L; Calza, L; Colangeli, V; Magistrelli, E; Re, MC; Viale, P | 1 |
| Emanuel, K; Fox, HS; Lamberty, BG; Morsey, B; Stauch, KL | 1 |
1 review(s) available for nevirapine and raltegravir potassium
| Article | Year |
|---|---|
Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid).
Topics: Adenine; Adult; Amniotic Fluid; Anti-HIV Agents; Cyclohexanes; Enfuvirtide; Female; Fetal Blood; Fetus; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Maraviroc; Nevirapine; Organophosphonates; Peptide Fragments; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Tenofovir; Triazoles; Viral Load; Zidovudine | 2011 |
2 trial(s) available for nevirapine and raltegravir potassium
| Article | Year |
|---|---|
Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Endoscopy; Female; Gastrointestinal Tract; Humans; Immune Reconstitution Inflammatory Syndrome; Immunohistochemistry; Lymphocyte Activation; Lymphoid Tissue; Male; Nevirapine; Nitriles; Pyridazines; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load | 2012 |
Effect of efavirenz, nevirapine, etravirine, and raltegravir administration on the pharmacokinetics of ritonavir-boosted darunavir in a population of HIV-infected patients.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Darunavir; Drug Synergism; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Nevirapine; Nitriles; Pyridazines; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Ritonavir; Sulfonamides | 2013 |
9 other study(ies) available for nevirapine and raltegravir potassium
| Article | Year |
|---|---|
Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis.
Topics: Animals; Antiviral Agents; Autoradiography; beta-Galactosidase; Carbamates; Cell Line, Tumor; Cell Survival; Chickens; Dihydroorotate Dehydrogenase; DNA Primers; Furans; Humans; Indoles; Lamivudine; Mammals; Nevirapine; Oxadiazoles; Oxidoreductases Acting on CH-CH Group Donors; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Species Specificity; Sulfonamides; Time Factors; Virus Replication; Viruses | 2011 |
Low risk of liver toxicity using the most recently approved antiretroviral agents but still increased in HIV-hepatitis C virus coinfected patients.
Topics: Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Coinfection; Cyclopropanes; Darunavir; Female; Follow-Up Studies; Hepatitis C; HIV Infections; Humans; Liver; Male; Nevirapine; Oligopeptides; Pyridines; Pyrrolidinones; Raltegravir Potassium; Ritonavir; Sulfonamides | 2013 |
Nevirapine-raltegravir combination, an NRTI and PI/r sparing regimen, as maintenance antiretroviral therapy in virologically suppressed HIV-1-infected patients.
Topics: Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Drug Combinations; Drug Substitution; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Male; Middle Aged; Nevirapine; Protease Inhibitors; Pyrrolidinones; Raltegravir Potassium; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Treatment Outcome; Viral Load | 2014 |
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV; HIV Infections; Humans; Maintenance Chemotherapy; Male; Middle Aged; Nevirapine; Raltegravir Potassium; RNA, Viral; Viral Load | 2015 |
Improvement in renal function and bone mineral density after a switch from tenofovir/emtricitabine plus ritonavir-boosted protease inhibitor to raltegravir plus nevirapine: a pilot study.
Topics: Adult; Anti-HIV Agents; Bone Density; Cohort Studies; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Middle Aged; Nevirapine; Pilot Projects; Raltegravir Potassium; Ritonavir | 2016 |
Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics.
Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV Integrase Inhibitors; Humans; Maintenance Chemotherapy; Male; Middle Aged; Nevirapine; Raltegravir Potassium; Retrospective Studies; Viral Load | 2016 |
Protein expression from unintegrated HIV-1 DNA introduces bias in primary in vitro post-integration latency models.
Topics: Alkynes; Benzoxazines; CD4-Positive T-Lymphocytes; Cyclopropanes; DNA, Viral; Genes, Reporter; Green Fluorescent Proteins; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Lymphocyte Activation; Models, Biological; Nevirapine; Primary Cell Culture; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Ritonavir; Viral Proteins; Virus Integration; Virus Latency; Virus Replication | 2016 |
Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study).
Topics: Adult; Anti-HIV Agents; Anticholesteremic Agents; Antiretroviral Therapy, Highly Active; Cholesterol, LDL; Cohort Studies; Drug Substitution; Female; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Hyperlipidemias; Male; Middle Aged; Nevirapine; Prospective Studies; Raltegravir Potassium; Ritonavir; Rosuvastatin Calcium; Viral Load; Viremia | 2017 |
Central nervous system-penetrating antiretrovirals impair energetic reserve in striatal nerve terminals.
Topics: Adenosine Triphosphate; Alkynes; Animals; Anti-HIV Agents; Benzoxazines; Cerebral Cortex; Corpus Striatum; Cyclohexanes; Cyclopropanes; Darunavir; Dideoxynucleosides; Dose-Response Relationship, Drug; Emtricitabine; Lopinavir; Male; Maraviroc; Mitochondria; Neurons; Nevirapine; Oxidative Phosphorylation; Permeability; Presynaptic Terminals; Raltegravir Potassium; Rats; Rats, Long-Evans; Triazoles; Zidovudine | 2017 |